Poly-D-lysine hydrobromide is a synthetic polypeptide composed of D-amino acids linked together by peptide bonds. This compound is water-soluble and biocompatible, making it ideal for use in biological research and pharmaceutical applications. One of the main properties of poly-D-lysine hydrobromide is its ability to enhance cell adhesion and promote cell growth on a variety of surfaces. This property is particularly valuable in drug discovery, as the interaction between cells and potential drug candidates plays a crucial role in determining their efficacy and safety.
Poly-D-lysine hydrobromide is frequently used in drug development as a coating agent for cell culture plates and other surfaces to encourage cell adhesion and proliferation. Poly-D-lysine hydrobromide facilitates researchers' ability to examine the impact of diverse cell types and model systems on possible therapeutic compounds by offering a stable and favorable culture environment. Prior to moving innovative therapies into preclinical and clinical trials, this is crucial for assessing their efficacy, toxicity, and mode of action.
Moreover, biomolecules like proteins, peptides, and nucleic acids can be immobilized using poly-D-lysine hydrobromide as a molecular scaffold. Through the functionalization of poly-D-lysine hydrobromide's polymer backbone with particular ligands or targeting moieties, researchers can design tailored platforms for drug delivery, target validation, and drug screening. Poly-D-lysine hydrobromide is a flexible tool that may be tailored to unique research requirements, which makes it ideal for use in drug development.
Poly-D-lysine hydrobromide is useful in cell culture and biomolecule immobilization, but it may also be used in drug delivery systems. Researchers can increase the stability, targeting effectiveness, and bioavailability of therapeutic medicines by conjugating them to poly-D-lysine hydrobromide or integrating them into poly-D-lysine hydrobromide nanoparticles. This will increase the pharmaceuticals' therapeutic efficacy. This method is very helpful in the development of novel medicines for a range of illnesses, such as infectious diseases, cancer, and neurological disorders.
Furthermore, it has been demonstrated that poly-D-lysine hydrobromide modifies gene expression profiles and cell signaling pathways, which influences how cells react to medication treatments. Through the co-administration of poly-D-lysine hydrobromide with therapeutic candidates or the utilization of poly-D-lysine hydrobromide drug delivery systems, researchers have the ability to enhance the effectiveness of current medications or uncover novel approaches for addressing difficult medical conditions.
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-110982788-A | Method for inducing transdifferentiation of satellite glial cells into neurons | 2019-12-25 |
| CN-110982788-B | Method for inducing transdifferentiation of satellite glial cells into neurons | 2019-12-25 |
| WO-2021045182-A1 | Tryptase activity measurement substrate | 2019-09-05 |
| WO-2020263772-A1 | Cell scaffold comprising an electronic circuit | 2019-06-24 |
| CN-113613633-A | Fusogenic liposome compositions for CNS delivery | 2018-11-14 |
| CN-113631718-A | Compositions and methods for compartment-specific cargo delivery | 2018-11-14 |
| CN-112955174-A | Fusogenic liposome compositions and uses thereof | 2018-07-09 |
| CN-112272706-A | Compositions and methods for membrane protein delivery | 2018-02-17 |
| CN-111655292-A | Cellular biologicals and therapeutic uses thereof | 2017-12-07 |
| CN-107119010-B | Synthetic adhesion culture medium for cell culture and preparation method thereof | 2017-07-14 |
